Publications by authors named "E Yunihastuti"
Background/objectives: As people with human immunodeficiency virus experience longer life expectancy, other causes of morbidity and mortality are being increasingly identified. The incidence of non-alcoholic fatty liver disease has recently been on the rise in Indonesia. People with human immunodeficiency virus on antiretroviral therapy are also at an increased risk of having non-alcoholic fatty liver disease.
View Article and Find Full Text PDFBackground: There are still many patients newly diagnosed with HIV at an advanced stage in Indonesia. We aimed to identify factors associated with 1-year mortality among cytomegalovirus (CMV)-infected people living with HIV (PLHIV).
Methods: This retrospective cohort study was carried out at a tertiary-care hospital in Jakarta, Indonesia (January 2017 to December 2022).
Article Synopsis
- Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a chronic liver condition, with patients at higher risk of dying from coronary artery disease (CAD), yet the link between liver fat and heart disease is not fully understood.
- A study examined 124 adult patients with significant CAD and found a notable correlation between liver fat severity (measured by Controlled Attenuation Parameter or CAP) and the SYNTAX score (which assesses the complexity of coronary artery disease).
- Results showed patients with severe liver fat (high CAP values) often also had higher SYNTAX scores, suggesting that those with significant liver steatosis should be monitored for heart disease and encouraged to adopt healthier lifestyles.
Introduction: Toxoplasma gondii can cause symptomatic toxoplasmosis in immunodeficient hosts, including in people living with human immunodeficiency virus (PLWH), mainly because of the reactivation of latent infection. We assessed the prevalence of toxoplasmosis and its associated risk factors in PLWH in the Asia-Pacific region using data from the TREAT Asia Human Immunodeficiency Virus (HIV) Observational Database (TAHOD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific.
Methods: This study included both retrospective and prospective cases of toxoplasmosis reported between 1997 and 2020.
: The COVID-19 pandemic has led to high mortality rates. There have been reports of hypersensitivity reactions with mild to severe symptoms. The COVID-19 vaccine provocation test is a vaccination protocol for individuals with a history of hypersensitivity.
View Article and Find Full Text PDF